Novel Nontoxic 5,9-Disubstituted SN38 Derivatives: Characterization of Their Pharmacological Properties and Interactions with DNA Oligomers

Int J Mol Sci. 2021 Jul 30;22(15):8190. doi: 10.3390/ijms22158190.

Abstract

Novel nontoxic derivatives of SN38 with favorable antineoplastic properties were characterized in water solution using NMR. The phenomena observed by NMR were linked to basic pharmacological properties, such as solubility, bioavailability, chemical and stereochemical stability, and binding to natural DNA oligomers through the terminal G-C base pair, which is commonly considered a biological target of Topo I inhibitors. Compound 1, with bulky substituents at both C5(R) and C20(S) on the same side of a camptothecin core, manifests self-association, whereas diastereomers 2, with bulky C5(S) and C20(S) substituents are mostly monomeric in solution. The stereogenic center at C5 is stable in water solution at pH 5-6. The compound with an (N-azetidinyl)methyl substituent at C9 can undergo the retro Mannich reaction after a prolonged time in water solution. Both diastereomers exhibit different abilities in terms of binding to DNA oligomers: compound 1 is strongly bound, whereas the binding of compound 2 is rather weak. Molecular modeling produced results consistent with NMR experiments. These complementary data allow linking of the observed phenomena in NMR experiments to basic preliminary information on the pharmacodynamic character of compounds and are essential for planning further development research.

Keywords: 1H/13C NMR; DNA complexes; DOSY; camptothecin; molecular modeling.

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / toxicity
  • DNA / chemistry*
  • Irinotecan / analogs & derivatives*
  • Irinotecan / toxicity
  • Molecular Docking Simulation*
  • Topoisomerase I Inhibitors / chemistry*
  • Topoisomerase I Inhibitors / toxicity

Substances

  • Antineoplastic Agents
  • Topoisomerase I Inhibitors
  • Irinotecan
  • DNA